Skip to main content

Table 3 Group III, cases diagnosed with endometrioid adenocarcinomas

From: Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience

Case no. HER2/neu Primary site Histopathology diagnosis
IHC FISH Result Type FIGO Nuc
1 0 1.4 NEG Endometrium ENAdCA 2 3
2 0 1.15 NEG Endometrium ENAdCA 2 2
3 0 1.05 NEG Endometrium ENAdCA 2 2
4 1+ 0.98 NEG Endometrium ENAdCA 1 1
5 1+ 0.98 NEG Endometrium ENAdCA 1 2
6 0 NP NEG Fallopian Tube ENAdCA 2 2
7 1+ NP NEG Endometrium ENAdCA 1 2
8 1+ 1 NEG Endometrium ENAdCA 1 1
9 1+ NP NEG Endometrium ENAdCA 2 2
10 1+ NP NEG Ovary ENAdCA 3 3
11 0 NP NEG Endometrium ENAdCA 1 1
12 1+ NP NEG Endometrium ENAdCA 2 3
13 0 NP NEG Endometrium ENAdCA 2 2
14 0 NP NEG Ovary ENAdCA 3 3
15 1+ NP NEG Endometrium ENAdCA 2 2
16 1+ NP NEG Endometrium ENAdCA 2 2
17 1+ NP NEG Endometrium ENAdCA 3 2
18 0 NP NEG Ovary ENAdCA 3 3
19 1+ NP NEG Endometrium ENAdCA 1 2
20 0 NP NEG Endometrium ENAdCA 2 1
21 1+ NP NEG Endometrium ENAdCA 1 2
22 1+ NP NEG Endometrium ENAdCA 1 2
23 1+ NP NEG Endometrium ENAdCA 1 1
24 1+ NP NEG Endometrium ENAdCA 2 1
25 0 NP NEG Ovary ENAdCA 3 3
26 1+ NP NEG Endometrium ENAdCA 2 1
27 0 NP NEG Endometrium ENAdCA 2 2
28 0 NP NEG Ovary ENAdCA 3 3
  1. IHC immunohistochemistry score, FISH fluorescence in-situ hybridization HER2/CEP17 ratio, FIGO FIGO grade, Nuc nuclear grade, NP not performed, NEG negative, ENAdCA endometrioid adenocarcinoma